ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2195

Expanding The Spectrum Of Recombination Activating Gene-1 Deficiency To Include Early Onset Autoimmunity

Lauren A. Henderson1, Francesco Frugoni1, Gregory Hopkins2, Helen de Boer2, Sung-Yun Pai2,3, Yu Nee Lee1, Jolan E. Walter4, Melissa M. Hazen1 and Luigi D Notarangelo5,6, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, 3Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 4Division of Allergy/Immunology, Massachusetts General Hospital for Children, Boston, MA, 5Division of Immunology and The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, 6Harvard Stem Cell Institute, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Auto-immunity, immune deficiency, Immune Dysregulation, pediatric rheumatology and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: We sought to identify the etiology of early onset autoimmunity and T cell lymphopenia in two siblings through genetic and functional studies.  Newborn screening identified a full term infant (Patient B) with undetectable T-cell receptor excision circles, raising a concern for severe combined immunodeficiency (SCID).  A female sibling (Patient A) had died at 2 years of age secondary to complications from autoimmunity.  At 6 months, Patient A had developed vasculitis leading to digital necrosis, myositis, autoimmune cytopenias, positive autoantibodies (ANA, anti-cardiolipin, thyroid peroxidase, and thryroglobulin), elevated inflammatory markers, and hypocomplementia.  Both children were severely T cell lymphopenic with poor lymphocyte proliferation to mitogens, although natural killer cells, B lymphocytes, and immunoglobulin levels were preserved.  Due to the sibling’s ultimate fatality, Patient B received prophylactic antibiotics and IVIG; the child never developed autoimmunity and underwent a successful bone marrow transplant at 3 months of age.

Methods: Genomic analysis was done on DNA extracted from whole blood.  Recombinase activity was explored using Abelson-immortalized murine Rag1-/- pro-B cells with an intrachromosomal inverted GFP cassette flanked by recombination signal sequences.  The Abelson pro-B cells were transduced with vectors encoding either wild type or mutant RAG1 alleles.  Recombination-dependent expression of GFP served as an indicator of RAG1 activity.  The Abelson system was also used to assess RAG1 protein expression through immunoblotting.  Expression of TCRVβ families in CD3+ cells was detected using monoclonal antibodies conjugated to fluorochromes.  The B cell repertoire was evaluated by pyrosequencing.   

Results: Testing in Patient A for mutations classically associated with T–B+SCID was unrevealing.  Patient B had compound heterozygous missense mutations in RAG1 (c.2522 G>A, p.R841Q; c.2920 T>C, p.F974L).  Analysis of frozen genomic DNA from Patient A confirmed identical RAG1mutations.  The parents were carriers (paternal allele:  p.R841Q; maternal allele:  p.F974L).  In the Abelson system, the R841 mutant lacked protein expression and recombinase activity while the F974L mutant demonstrated normal protein expression but reduced activity (56.5% of wild type).  In Patient B, the T cell repertoire was oligoclonal with 8/24 TCRVβ families falling in normal range.  The restricted T cell diversity corrected after transplant.  By pyrosequencing, the usage of variable, diversity, and joining (V(D)J) segments was skewed in the B cells.     

Conclusion: Lymphocyte receptor diversity is generated by the activity of RAG1 and 2, which create DNA breaks that allow recombination of V(D)J gene segments.  The clinical presentation of RAG deficiency ranges from T–B–SCID to isolated CD4+ lymphopenia with the variability partially explained by the residual activity of RAG1.  We describe a novel presentation of hypomorphic RAG deficiency characterized by early onset autoimmunity in the presence of B cells, highlighting the importance of considering immunodeficiencies in children who present with immune dysregulation, as prompt treatment can be lifesaving.


Disclosure:

L. A. Henderson,
None;

F. Frugoni,
None;

G. Hopkins,
None;

H. de Boer,
None;

S. Y. Pai,
None;

Y. N. Lee,
None;

J. E. Walter,
None;

M. M. Hazen,
None;

L. D. Notarangelo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanding-the-spectrum-of-recombination-activating-gene-1-deficiency-to-include-early-onset-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology